Warfarin: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>David E. Volk
m (typo)
imported>David E. Volk
m (IUPAC name)
Line 2: Line 2:
[[Image:Warfarin structure.jpg|right|thumb|200px|{{#ifexist:Template:Warfarin structure.jpg/credit|{{Warfarin structure.jpg/credit}}<br/>|}}Structure of Warfarin.]]  
[[Image:Warfarin structure.jpg|right|thumb|200px|{{#ifexist:Template:Warfarin structure.jpg/credit|{{Warfarin structure.jpg/credit}}<br/>|}}Structure of Warfarin.]]  


'''Warfarin''' is a an [[anticoagulant]] medication used prophylactically to suppress the formation of [[thrombosis]] and [[embolism]].  It was originally designed to be a rat poison.  It works as an anticogulant by suppressing the enzyme [[epoxide reductase]] in the liver, thereby suppresing the formation of the reduced form of [[vitamine K]] epoxide, which is needed for the synthesis of many coagulation factors.
'''Warfarin''' (IUPAC name
4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one) is a an [[anticoagulant]] medication used prophylactically to suppress the formation of [[thrombosis]] and [[embolism]].  It was originally designed to be a rat poison.  It works as an anticogulant by suppressing the enzyme [[epoxide reductase]] in the liver, thereby suppresing the formation of the reduced form of [[vitamine K]] epoxide, which is needed for the synthesis of many coagulation factors.

Revision as of 12:20, 22 January 2008

This article is developed but not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
Catalogs [?]
 
This editable, developed Main Article is subject to a disclaimer.
(CC) Image: David E. Volk
Structure of Warfarin.

Warfarin (IUPAC name 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one) is a an anticoagulant medication used prophylactically to suppress the formation of thrombosis and embolism. It was originally designed to be a rat poison. It works as an anticogulant by suppressing the enzyme epoxide reductase in the liver, thereby suppresing the formation of the reduced form of vitamine K epoxide, which is needed for the synthesis of many coagulation factors.